About Aelis Farma
Aelis Farma is a company based in Bordeaux (France) founded in 2013.. Aelis Farma has raised $14.04 million across 3 funding rounds from investors including Bpifrance, European Union and NACo. The company has 28 employees as of December 31, 2024. Aelis Farma offers products and services including AEF0117 and AEF0217. Aelis Farma operates in a competitive market with competitors including Indivior, Biotie, Ethypharm, Braeburn and Opiant Pharmaceuticals, among others.
- Headquarter Bordeaux, France
- Employees 28 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aelis Farma Sa
-
Annual Revenue
$2.78 M (USD)-70.42as on Dec 31, 2024
-
Net Profit
$-7.75 M (USD)-46.83as on Dec 31, 2024
-
EBITDA
$-10.75 M (USD)-7.86as on Dec 31, 2024
-
Total Equity Funding
$14.04 M (USD)
in 3 rounds
-
Latest Funding Round
$4.05 M (USD), Grant
Feb 01, 2021
-
Investors
Bpifrance
& 7 more
-
Employee Count
28
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aelis Farma
Aelis Farma is a publicly listed company on the EURONEXT with ticker symbol AELIS in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aelis Farma
Aelis Farma offers a comprehensive portfolio of products and services, including AEF0117 and AEF0217. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets cannabis use disorder through CB1 inhibition
Addresses cognitive deficits in conditions like Down syndrome
Unlock access to complete
Unlock access to complete
Funding Insights of Aelis Farma
Aelis Farma has successfully raised a total of $14.04M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $4.05 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $4.1M
-
First Round
First Round
(27 Mar 2014)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Grant - Aelis Farma | Valuation |
investors |
|
| Dec, 2019 | Amount | Seed - Aelis Farma | Valuation | Inserm Transfert , Bpifrance | |
| Mar, 2014 | Amount | Seed - Aelis Farma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aelis Farma
Aelis Farma has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, European Union and NACo. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward early-stage healthcare companies in France.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Early to Growth stage VC & PE firm funding
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aelis Farma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aelis Farma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aelis Farma Comparisons
Competitors of Aelis Farma
Aelis Farma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indivior, Biotie, Ethypharm, Braeburn and Opiant Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for opioid addiction treatment are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Drugs for neurodegenerative and psychiatric disorders are developed by Biotie.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Long-acting therapies for opioid addiction and chronic pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for addictive and eating disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for substance use disorders are developed by Amygdala Neurosciences.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aelis Farma
Frequently Asked Questions about Aelis Farma
When was Aelis Farma founded?
Aelis Farma was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Aelis Farma located?
Aelis Farma is headquartered in Bordeaux, France.
Who is the current CEO of Aelis Farma?
Pier Vincenzo Piazza is the current CEO of Aelis Farma.
Is Aelis Farma a funded company?
Aelis Farma is a funded company, having raised a total of $14.04M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.79M, raised on Mar 27, 2014.
How many employees does Aelis Farma have?
As of Dec 31, 2024, the latest employee count at Aelis Farma is 28.
What is the annual revenue of Aelis Farma?
Annual revenue of Aelis Farma is $2.78M as on Dec 31, 2024.
What does Aelis Farma do?
Aelis Farma was founded in 2013 in Bordeaux, France, as a biopharmaceutical company focused on CNS therapeutics. Small molecule inhibitors specific to CB1 receptor signaling are developed using a platform derived from the neurosteroid pregnenolone. Lead candidate AEF0117 addresses cannabis use disorder, while AEF0118 targets metabolic and fibrotic conditions. Operations emphasize preclinical and clinical advancement in the neurology sector.
Who are the top competitors of Aelis Farma?
Aelis Farma's top competitors include Indivior, Ethypharm and Amygdala Neurosciences.
What products or services does Aelis Farma offer?
Aelis Farma offers AEF0117 and AEF0217.
Is Aelis Farma publicly traded?
Yes, Aelis Farma is publicly traded on EURONEXT under the ticker symbol AELIS.
Who are Aelis Farma's investors?
Aelis Farma has 8 investors. Key investors include Bpifrance, European Union, NACo, Nouvelle-Aquitaine, and Inserm Transfert.
What is Aelis Farma's ticker symbol?
The ticker symbol of Aelis Farma is AELIS on EURONEXT.